• 00:00 1.
    index 1
  • 01:24 2.
    HBx-downregulated circSFMBT2 in HCC cell lines
  • 12:05 3.
    HBx-downregulated circSFMBT2 in HCC cell lines
  • 16:00 4.
    Level of CircSFMBT2 in HBV(+) or HBV(-) tumorous tissues and paired adjacent nontumorous tissues
  • 16:52 5.
    CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
  • 23:51 6.
    CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
  • 28:40 7.
    CircSFMBT2 inhibits HCC metastasis in vitro
  • 28:46 8.
    CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
  • 34:15 9.
    CircSFMBT2 inhibits HCC metastasis in vitro
  • 35:44 10.
    CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
  • 35:45 11.
    CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
  • 35:46 12.
    Level of CircSFMBT2 in HBV(+) or HBV(-) tumorous tissues and paired adjacent nontumorous tissues
  • 35:47 13.
    HBx-downregulated circSFMBT2 in HCC cell lines
  • 35:50 14.
    HBx-downregulated circSFMBT2 in HCC cell lines
  • 36:32 15.
    HBx-downregulated circSFMBT2 in HCC cell lines
  • 36:32 16.
    Level of CircSFMBT2 in HBV(+) or HBV(-) tumorous tissues and paired adjacent nontumorous tissues
  • 36:33 17.
    CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
  • 36:39 18.
    CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
  • 36:39 19.
    CircSFMBT2 inhibits HCC metastasis in vitro
  • 42:59 20.
    CircSFMBT2 inhibits HCC metastasis in vitro
  • 45:58 21.
    CircSFMBT2 inhibits HCC metastasis in vitro
  • 46:02 22.
    CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
  • 46:02 23.
    CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
  • 47:03 24.
    CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
  • 47:03 25.
    CircSFMBT2 inhibits HCC metastasis in vitro
  • 47:05 26.
    CircSFMBT2 inhibits HCC metastasis in vitro
  • 47:07 27.
    CircSFMBT2 inhibits HCC metastasis in vivo
  • 50:41 28.
    CircSFMBT2 acts as a sponge of miR-665
  • 1:02:07 29.
    CircSFMBT2 acts as a sponge of miR-665
  • 1:02:11 30.
    CircSFMBT2 acts as a sponge of miR-665
  • 1:04:23 31.
    CircSFMBT2 acts as a sponge of miR-665
  • 1:07:59 32.
    CircSFMBT2 acts as a sponge of miR-665
  • 1:08:05 33.
    CircSFMBT2 acts as a sponge of miR-665
  • 1:08:54 34.
    CircSFMBT2 acts as a sponge of miR-665
  • 1:09:46 35.
    CircSFMBT2 regulates HCC metastasis through the miR-665/TIMP3 axis
  • 1:11:41 36.
    CircSFMBT2 regulates HCC metastasis through the miR-665/TIMP3 axis
  • 1:16:17 37.
    CircSFMBT2 regulates HCC metastasis through the miR-665/TIMP3 axis
  • 1:17:20 38.
    HBx facilitates HCC metastasis through circSFMBT2/miR-665/TIMP3 pathways
  • 1:17:26 39.
    HBx facilitates HCC metastasis through circSFMBT2/miR-665/TIMP3 pathways
  • 1:17:36 40.
    HBx facilitates HCC metastasis through circSFMBT2/miR-665/TIMP3 pathways
  • 1:17:40 41.
    HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
  • 1:20:56 42.
    HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
  • 1:21:04 43.
    HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
  • 1:21:57 44.
    HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
  • 1:22:38 45.
    HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
  • 1:23:50 46.
    Slide 24
  • Index
  • Notes
  • Comment
  • Fullscreen
20221017 lab meeting_照穎
Duration: 1:25:35, Browse: 224, Last Updated: 2022-10-17
    • 00:00 1.
      index 1
    • 01:24 2.
      HBx-downregulated circSFMBT2 in HCC cell lines
    • 12:05 3.
      HBx-downregulated circSFMBT2 in HCC cell lines
    • 16:00 4.
      Level of CircSFMBT2 in HBV(+) or HBV(-) tumorous tissues and paired adjacent nontumorous tissues
    • 16:52 5.
      CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
    • 23:51 6.
      CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
    • 28:40 7.
      CircSFMBT2 inhibits HCC metastasis in vitro
    • 28:46 8.
      CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
    • 34:15 9.
      CircSFMBT2 inhibits HCC metastasis in vitro
    • 35:44 10.
      CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
    • 35:45 11.
      CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
    • 35:46 12.
      Level of CircSFMBT2 in HBV(+) or HBV(-) tumorous tissues and paired adjacent nontumorous tissues
    • 35:47 13.
      HBx-downregulated circSFMBT2 in HCC cell lines
    • 35:50 14.
      HBx-downregulated circSFMBT2 in HCC cell lines
    • 36:32 15.
      HBx-downregulated circSFMBT2 in HCC cell lines
    • 36:32 16.
      Level of CircSFMBT2 in HBV(+) or HBV(-) tumorous tissues and paired adjacent nontumorous tissues
    • 36:33 17.
      CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
    • 36:39 18.
      CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
    • 36:39 19.
      CircSFMBT2 inhibits HCC metastasis in vitro
    • 42:59 20.
      CircSFMBT2 inhibits HCC metastasis in vitro
    • 45:58 21.
      CircSFMBT2 inhibits HCC metastasis in vitro
    • 46:02 22.
      CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
    • 46:02 23.
      CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
    • 47:03 24.
      CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
    • 47:03 25.
      CircSFMBT2 inhibits HCC metastasis in vitro
    • 47:05 26.
      CircSFMBT2 inhibits HCC metastasis in vitro
    • 47:07 27.
      CircSFMBT2 inhibits HCC metastasis in vivo
    • 50:41 28.
      CircSFMBT2 acts as a sponge of miR-665
    • 1:02:07 29.
      CircSFMBT2 acts as a sponge of miR-665
    • 1:02:11 30.
      CircSFMBT2 acts as a sponge of miR-665
    • 1:04:23 31.
      CircSFMBT2 acts as a sponge of miR-665
    • 1:07:59 32.
      CircSFMBT2 acts as a sponge of miR-665
    • 1:08:05 33.
      CircSFMBT2 acts as a sponge of miR-665
    • 1:08:54 34.
      CircSFMBT2 acts as a sponge of miR-665
    • 1:09:46 35.
      CircSFMBT2 regulates HCC metastasis through the miR-665/TIMP3 axis
    • 1:11:41 36.
      CircSFMBT2 regulates HCC metastasis through the miR-665/TIMP3 axis
    • 1:16:17 37.
      CircSFMBT2 regulates HCC metastasis through the miR-665/TIMP3 axis
    • 1:17:20 38.
      HBx facilitates HCC metastasis through circSFMBT2/miR-665/TIMP3 pathways
    • 1:17:26 39.
      HBx facilitates HCC metastasis through circSFMBT2/miR-665/TIMP3 pathways
    • 1:17:36 40.
      HBx facilitates HCC metastasis through circSFMBT2/miR-665/TIMP3 pathways
    • 1:17:40 41.
      HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
    • 1:20:56 42.
      HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
    • 1:21:04 43.
      HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
    • 1:21:57 44.
      HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
    • 1:22:38 45.
      HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
    • 1:23:50 46.
      Slide 24
    Location
    Folder name
    2022
    Author
    黃照穎
    Branch
    賴亮全教授
    Created
    2022-10-17 11:57:37
    Last Updated
    2022-10-17 12:40:22
    Duration
    1:25:35